P. Girard et al., SHOULD THE NUMBER OF PULMONARY METASTASES INFLUENCE THE SURGICAL DECISION, European journal of cardio-thoracic surgery, 12(3), 1997, pp. 385-391
Objective: To assess, using a large homogeneous retrospective series,
the prognostic value of the number of resected pulmonary metastases, a
nd thus, to determine to what extent the number of resectable metastas
es should influence the surgical decision. Methods: The survival analy
sis of all patients operated on for pulmonary metastases at a single c
enter, the comparisons of 2 'histologic' groups (sarcoma and carcinoma
) and, within each histologic group, of three subgroups with different
numbers of resected metastases (1, 2-4, and greater than or equal to
5) were performed. The log-rank test was used to compare survival curv
es. Results: Among 575 adult patients operated on with curative intent
before December 1991, the first operation allowed the complete resect
ion of a known number of histologically proven viable pulmonary metast
ases in 230 and 151 patients with metastases from carcinoma and sarcom
a, respectively. The 5- and 10-year probabilities of survival (Kaplan-
Meier) were 37 and 23%, respectively in carcinoma patients, and 31 and
28%, respectively in sarcoma patients (log-rank test: ns). Only the d
ifference between patients with 1 versus 2-4 metastases from carcinoma
proved statistically significant (P = 0.02), with 5-year survival est
imates of 41 and 25%, respectively. Beside survival, the only signific
ant difference between the subgroups of patients with different number
s of resected metastases was the mean interval between the diagnosis o
f pulmonary metastases and the resection of pulmonary metastases, whic
h was significantly longer in patients with several metastases in both
histologic groups. Conclusions: In patients with resectable pulmonary
metastases from sarcoma or carcinoma, the number of metastases should
have little influence on the surgical decision, except for delaying t
his decision in patients with several metastases until a significant i
nterval, with or without treatment, has shown that metastatic disease
remains resectable and confined to the lungs. (C) 1997 Elsevier Scienc
e B.V.